Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-06-055418
Filing Date
2006-03-16
Accepted
2006-03-15 21:06:22
Documents
7
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2005 d10k.htm 10-K 1075235
2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 3710
3 CERTIFICATION OF CHIEF EXECUTIVE OFFICER OF TERCICA, INC. dex311.htm EX-31.1 6026
4 CERTIFICATION OF CHIEF FINANCIAL OFFICER OF TERCICA, INC. dex312.htm EX-31.2 5982
5 CERTIFICATION BY THE CHIEF EXECUTIVE OFFICER, AS REQUIRED BY RULE 13A-14(B) dex321.htm EX-32.1 3493
6 CERTIFICATION BY THE CHIEF FINANCIAL OFFICER, AS REQUIRED BY RULE 13A-14(B) dex322.htm EX-32.2 3464
7 GRAPHIC g94097g80r38.jpg GRAPHIC 108063
  Complete submission text file 0001193125-06-055418.txt   1248371
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005 6506244900
TERCICA INC (Filer) CIK: 0001262175 (see all company filings)

EIN.: 260042539 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50461 | Film No.: 06689848
SIC: 2834 Pharmaceutical Preparations